Prox Ventures

Tuanxiang Pharmaceutical is an innovative drug research and development company that combines traditional new drug research and development with the use of the world's leading unique phase separation technology.

LinkZill is a high-tech company specializing in the development and supply of organic semiconductor materials and thin-film transistors (TFT) arrays. Its innovative products cater to various emerging industries, including biomedical electronics, healthcare, and intelligent sports, as well as novel printed display technologies. By focusing on organic materials, LinkZill aims to support advancements in these fields, leveraging its expertise to provide solutions that meet the demands of modern technology.

iView Therapeutics, Inc. is a pharmaceutical company specializing in the development of topical drugs and medical devices across various therapeutic areas, including ophthalmology, dermatology, otolaryngology, and gynecology. Founded in 2015 by Bo Liang and John Baldwin, and headquartered in Doylestown, Pennsylvania, the company focuses on innovative treatments, particularly for viral conjunctivitis, utilizing its proprietary povidone iodine platform technology. This technology combines polyvinylpyrrolidone and iodine to create a potent disinfectant effective against a wide range of pathogens, including viruses, bacteria, fungi, and mold spores. iView Therapeutics' product line includes formulations such as povidone iodine slow-releasing eye drops, PVP-iodine sprays, and nasal irrigation solutions, aimed at addressing specific medical conditions while enhancing therapeutic outcomes.

Chentai New Materials integrates the R&D, design, manufacturing, and sales of high-performance composite ceramics. It Specializes in the innovation and creation of medical high-performance ceramic products.

Rapafusyn Pharmaceuticals licenses technology related to a novel class of natural product-like macrocycles and develops novel pharmaceuticals aimed at treating diseases with unmet medical needs. It focuses on non-degrading molecular glues designed to target intracellular and transmembrane proteins that are difficult to drug using conventional methods, offering cell permeability, selectivity, tunability, and potential for oral delivery. The company supports drug discovery and development by enabling inhibition of challenging targets, contributing to the development of new therapeutic approaches.

Rhino Medical develops advanced technologies with independent intellectual property rights. The founding team has rich experience in R&D, marketing, and clinical. On the basis of benchmarking imported phacoemulsification instruments and vitrectomy instruments

Cytonus Therapeutics, Inc. is a biotechnology company founded in 2018 and located in Columbus, Ohio. The company specializes in developing immune-oncology and gene therapies aimed at addressing devastating and rare diseases. Cytonus employs a synthetic biology approach through its proprietary Cargocyte technology, which enables precision delivery of therapeutics and in vivo production of innovative treatments. By integrating AI-driven drug discovery methods, Cytonus is focused on creating first-in-class therapeutics to treat immune-related disorders effectively.

Lifeshield Medical focuses on life support systems. The current products include a new generation of in vivo interventional cardiac support systems, extracorporeal carbon dioxide removal systems (ECCO2R) for the treatment of severe COPD and ECMO extracorporeal membrane oxygenation systems. The company is actively cooperating with domestic clinicians and continues to develop and industrialize several innovative life support system products and solutions such as heart, brain, lung, liver, and kidney to meet the clinical needs of the Chinese and EU markets and serve more patients.

Mingzhun Medical is an innovative medical devices company that aims first clinical application of cutting-edge optical microscopic imaging technology.

Zhenyi Yiliao is a medical enterprise focusing on structural heart disease.

Cytonus Therapeutics, Inc. is a biotechnology company founded in 2018 and located in Columbus, Ohio. The company specializes in developing immune-oncology and gene therapies aimed at addressing devastating and rare diseases. Cytonus employs a synthetic biology approach through its proprietary Cargocyte technology, which enables precision delivery of therapeutics and in vivo production of innovative treatments. By integrating AI-driven drug discovery methods, Cytonus is focused on creating first-in-class therapeutics to treat immune-related disorders effectively.

Daxiang Biotech develops and produces human organoid chips. It is committed to promoting organoid chips in new drug research and development, disease modeling, and individualization.

Founded in 2017, Coastar Therapeutics specializes in developing a proprietary erythrocyte enveloped virus delivery technology platform. This platform enables repeated virus dosing by evading immune system recognition and attack, addressing challenges in systemic drug therapies. Coastar's process technology focuses on red blood cell membranes, facilitating mass production and standardization with cost advantages. The company's initial product targets oncolytic viruses.

ViewGene is a gene therapy company that has developed a proprietary inducible and tissue-specific gene therapy platform in China. The platform reduces the potential risks of uncontrollable dose and overexpression of gene expression and overcomes the shortcomings of traditional gene therapy techniques such as tissue destruction, immunogenicity, inflammatory response, and short onset time in vivo. The highlights of its gene therapy drugs are the clear dose-response relationship and high safety, which have significant advantages in the treatment of single-gene genetic diseases.

Leadinno Medical Valley is a company that specializes in the production of medical devices aimed at neuroregulatory functions. It develops implantable neuroelectric stimulation products intended to treat various neurological functional diseases. The company emphasizes the use of innovative technologies to create wireless energy-carrying devices, which are designed to enhance patient comfort while simultaneously lowering treatment costs. By focusing on these advancements, Leadinno Medical Valley aims to improve the quality of care for individuals with neurological conditions.

VerImmune, based in Baltimore, Maryland, is an Immuno-Oncology company focused on developing innovative cancer therapies through its proprietary technology known as Anti-tumor Immune Redirection Virus-inspired Particles (AIR-ViPs). This first-in-class approach aims to harness and redirect pre-existing immune memory from pathogenic infections or childhood vaccines towards tumors. By doing so, VerImmune seeks to offer a transformative treatment option for patients with various types of cancers, especially those facing treatment resistance or limited therapeutic choices. The company's goal is to provide a low-toxicity solution that delivers durable benefits across a broad spectrum of cancer types.

BioHandler is a company focused on research and development, production, and sales of automation equipment and system solutions specifically for the life science industry. It specializes in creating intelligent automation equipment aimed at enhancing medical diagnostics. BioHandler provides customized solutions that range from high throughput units to comprehensive systems, catering to a variety of customer needs in large-scale test automation, high throughput drug screening, and automated clinical testing. The company's commitment to automating medical diagnostic processes positions it as a key player in advancing efficiency and accuracy within the healthcare sector.

VacV Biotherapeutics is a cancer immunotherapy company focused on developing innovative viral-based therapies utilizing a modified vaccinia virus platform. This platform enhances the virus's specificity for tumors, minimizes neurotoxicity, and improves therapeutic efficacy. By genetically modifying the virus, VacV Biotherapeutics increases the production of extracellular enveloped virus, allowing for safer and more efficient treatments. These therapies can be administered via intravenous injection, making them suitable for outpatient settings. The company's approach aims to stimulate the patient’s immune system to combat cancer while also targeting cancer cells directly, providing patients with access to novel treatments that can complement conventional anticancer therapies.

Hanglok-Tech focuses on surgical robotic solutions in the field of interventional radiology. The team has introduced distributed science into the field of surgical robots for the first time through a self-developed 'zhuqueyun' specialized robot operating system. Hanglok-Tech has completed the independent research and development layout, consisting of embedded systems, software engineering, artificial intelligence, and multiple hardware matrix. Hanglok-Tech has been dedicated to the three product pipelines of percutaneous intervention, bronchoscopy intervention, and endovascular intervention. The company is keen on unifying the design paradigm of robot products and their application in new scenes.

HROCT LITT Medtech has developed the unique SNP(Smart Needle Probe) needle imaging, assembled as a catheter, which OD is smaller than 1/5 of the traditional invasive OCT catheter, while the depth and resolution are all multiple times of the traditional invasive OCT catheter, achieving 1um level to supply the histopathology needed microimaging. The fiber could be compatible with different kinds of biopsy needles to access the targets, and also could be coupled with a specific laser to achieve OCT situ diagnosis and laser ablation. Its technology provides revolutionary solutions to neurosurgery, interventional pulmonology, neurovascular, nephropathy, mammary gland, cardiac, GI, and other fields.

Matridx is a company based in Hangzhou, China, specializing in the development, production, and sales of molecular diagnostic products aimed at diagnosing infectious diseases. The company utilizes advanced technologies such as CRISPR/Cas gene editing and high-throughput sequencing to create genetic testing kits that enhance the accuracy and efficiency of diagnostics. One of Matridx's notable offerings is the Potential Diagnostic Clue (PDC-Seq), which enables comprehensive sequencing of nucleic acids from samples taken from infected patients. By focusing on simplifying and accelerating the diagnostic process, Matridx aims to provide reliable genetic testing solutions that significantly improve the identification of infectious pathogens.

Cryofocus Biotech is a Shanghai-based cryoablation device manufacturer, focusing on the application of cryogenic technology in the field of cardiovascular interventional therapy.

Clerio Vision is a medical device company focused on refractive and ophthalmic technologies, including contact lenses and intraocular lenses. The company develops and commercializes next-generation products designed to address safety and performance concerns associated with current refractive procedures. Its laser-induced refractive index correction technology enables modification of the corneal refractive index to improve vision and treatment outcomes, offering physicians potential new options for vision correction. Founded in 2014, Clerio Vision is headquartered in Rochester, New York.

Matridx is a company based in Hangzhou, China, specializing in the development, production, and sales of molecular diagnostic products aimed at diagnosing infectious diseases. The company utilizes advanced technologies such as CRISPR/Cas gene editing and high-throughput sequencing to create genetic testing kits that enhance the accuracy and efficiency of diagnostics. One of Matridx's notable offerings is the Potential Diagnostic Clue (PDC-Seq), which enables comprehensive sequencing of nucleic acids from samples taken from infected patients. By focusing on simplifying and accelerating the diagnostic process, Matridx aims to provide reliable genetic testing solutions that significantly improve the identification of infectious pathogens.

Junling Healthcare is an innovative healthcare service company that mainly focuses on commercial personal health insurance, taking product and service innovation as the first responsibility, integrating high-quality medical service providers, and establishing an intelligent operation and risk control platform. The company creates three-dimensional services of the "medical, medicine, and information" network, providing one-stop products and risk control solutions for insurance companies and other related entities.

BreAX Biotech develops a breath-based diagnostic platform leveraging a proprietary single-photon ionization-time-of-flight mass spectrometer. It can provide sensitivity of pptv level (10-12) and a response speed of the second level, realizing high-sensitivity detection and real-time qualitative and quantitative analysis of VOCs in trace to ultra-trace concentrations (10-9~10-12). Breax's human exhaled breath detection mass spectrometer has obtained the NMPA registration certification, becoming the world's first breath detection mass spectrometry platform approved for clinical application. Breax's current clinical focus includes tuberculosis, malignant tumors, infectious diseases, and metabolic diseases.

Nanovision Technology, based in the Zhongguancun Yongfeng high-tech industrial base, specializes in high-speed and high-precision radiology imaging solutions. With a significant research and development presence in Yonyou Industrial Park and a subsidiary in Chengdu, the company focuses on static computed tomography (CT), X-ray CMOS detectors, and X-ray imaging software. Notably, Nanovision developed China's first self-designed CMOS flat panel detector, known as the Merak series, which serves a diverse range of applications across medical, industrial, and security sectors. By providing advanced technological support both domestically and internationally, Nanovision aims to enhance imaging capabilities in various fields.

Avotres is a biotechnology company focused on developing therapeutics for autoimmune diseases, cancer, and transplantation. It advances immunology-driven therapies by exploring how the immune system distinguishes self from non-self to address root causes of immune-related diseases and improve cancer treatment. The company develops monoclonal antibodies as potential cancer therapies that target novel immuno-oncology mechanisms.

ViewGene is a gene therapy company that has developed a proprietary inducible and tissue-specific gene therapy platform in China. The platform reduces the potential risks of uncontrollable dose and overexpression of gene expression and overcomes the shortcomings of traditional gene therapy techniques such as tissue destruction, immunogenicity, inflammatory response, and short onset time in vivo. The highlights of its gene therapy drugs are the clear dose-response relationship and high safety, which have significant advantages in the treatment of single-gene genetic diseases.

Robotrak Medtech is a technology-driven company focused on the development of innovative ophthalmic medical devices aimed at enhancing diagnosis and treatment in eye care. The company specializes in a range of products, including a fundus single-cell imaging system and an ophthalmic laser treatment robot. Additionally, Robotrak produces next-generation silicone hydrogel materials and contact lenses, along with solutions for youth myopia prevention and control. By leveraging advanced technologies such as laser, optical imaging, eye tracking, and artificial intelligence, Robotrak creates intelligent ophthalmic equipment that integrates both diagnosis and treatment. This enables earlier and more accurate observation and treatment of fundus lesions, ultimately providing efficient solutions for vision control.

PercAssist develops percutaneous balloon catheters designed to improve left ventricular function and promote myocardial recovery in patients with severe heart failure. Their battery-powered, non-blood contact extravascular device is procedurally simple and aims to reduce recovery time, decrease long-term complications and hospitalizations, thereby increasing survival and improving quality of life.

Great Bay Bio Ltd. is a biotechnology company based in Central, Hong Kong, founded in 2002. It specializes in drug discovery and development by leveraging artificial intelligence technology within its Chemistry, Manufacturing, and Control (CMC) platform. The company focuses on the research, development, and manufacturing of protein sequence products, including recombinant insulin-stimulating hormones and fusion proteins. Great Bay Bio aims to create innovative biopharmaceuticals through a digital platform that integrates big data and Internet of Things technology. By harnessing high-quality resources from regions including Europe, the United States, Singapore, and Hong Kong, the company seeks to enhance the efficiency of drug development, significantly shortening development cycles and reducing costs, thus providing competitive advantages in the biotechnology industry.

CD Biopharma is a biopharmaceutical company specializing in the development and commercialization of innovative tumor immunotherapy drugs. Its core pipeline revolves around PD-1AB21, a fusion protein combining a PD-1 antibody and IL-21, with complementary therapies including cell therapy, CART cell therapy, and tumor vaccines. The company's approach is guided by the principles of truth-seeking, innovation, precision, focus, and cooperation, integrating solid basic science with translational medicine.

Raymemo focuses on key technology for X-ray tube components. The current products cover medical diagnostic rotating anode X-ray tubes, tube components, and the sixth-generation static CT ray source modules. Raymemo is the first domestic CT tube manufacturer with independent forward design, development, and production capabilities. Its three major product lines cover all CT technology platforms in the market. The company was founded in 2017 and is based in Wuxi, China.

Reunion Biotech focuses on the research and development and industrial transformation of medical hydrogels. The company is committed to becoming an international leading hydrogel technology platform. The current pipeline includes systemic solutions for tumor radiotherapy protection, wound repair, tumor embolization, and drug delivery.

iView Therapeutics, Inc. is a pharmaceutical company specializing in the development of topical drugs and medical devices across various therapeutic areas, including ophthalmology, dermatology, otolaryngology, and gynecology. Founded in 2015 by Bo Liang and John Baldwin, and headquartered in Doylestown, Pennsylvania, the company focuses on innovative treatments, particularly for viral conjunctivitis, utilizing its proprietary povidone iodine platform technology. This technology combines polyvinylpyrrolidone and iodine to create a potent disinfectant effective against a wide range of pathogens, including viruses, bacteria, fungi, and mold spores. iView Therapeutics' product line includes formulations such as povidone iodine slow-releasing eye drops, PVP-iodine sprays, and nasal irrigation solutions, aimed at addressing specific medical conditions while enhancing therapeutic outcomes.

Cytonus Therapeutics, Inc. is a biotechnology company founded in 2018 and located in Columbus, Ohio. The company specializes in developing immune-oncology and gene therapies aimed at addressing devastating and rare diseases. Cytonus employs a synthetic biology approach through its proprietary Cargocyte technology, which enables precision delivery of therapeutics and in vivo production of innovative treatments. By integrating AI-driven drug discovery methods, Cytonus is focused on creating first-in-class therapeutics to treat immune-related disorders effectively.

Founded in 2017, Coastar Therapeutics specializes in developing a proprietary erythrocyte enveloped virus delivery technology platform. This platform enables repeated virus dosing by evading immune system recognition and attack, addressing challenges in systemic drug therapies. Coastar's process technology focuses on red blood cell membranes, facilitating mass production and standardization with cost advantages. The company's initial product targets oncolytic viruses.

Matridx is a company based in Hangzhou, China, specializing in the development, production, and sales of molecular diagnostic products aimed at diagnosing infectious diseases. The company utilizes advanced technologies such as CRISPR/Cas gene editing and high-throughput sequencing to create genetic testing kits that enhance the accuracy and efficiency of diagnostics. One of Matridx's notable offerings is the Potential Diagnostic Clue (PDC-Seq), which enables comprehensive sequencing of nucleic acids from samples taken from infected patients. By focusing on simplifying and accelerating the diagnostic process, Matridx aims to provide reliable genetic testing solutions that significantly improve the identification of infectious pathogens.

BrainHealth focuses on the research and development, production, and sales of neurological medical equipment.

Javelin Medical Ltd. is a medical device company founded in 2020 and based in Yokneam Illit, Israel. The company focuses on stroke prevention, specifically targeting individuals with abnormal heart rhythms. It has developed a permanent filter device, known as Vine, which is implanted in the carotid arteries. This device aims to prevent strokes by intercepting blood clots before they can reach the brain, thereby enhancing patient safety and outcomes in stroke-related healthcare.

Lifeshield Medical focuses on life support systems. The current products include a new generation of in vivo interventional cardiac support systems, extracorporeal carbon dioxide removal systems (ECCO2R) for the treatment of severe COPD and ECMO extracorporeal membrane oxygenation systems. The company is actively cooperating with domestic clinicians and continues to develop and industrialize several innovative life support system products and solutions such as heart, brain, lung, liver, and kidney to meet the clinical needs of the Chinese and EU markets and serve more patients.

MobiDrop Biotech specializes in developing microfluidic technologies tailored for life sciences and precision medicine. The company is dedicated to enhancing molecular diagnostics and life science research through innovative platforms that improve the accuracy and efficiency of diagnosis and testing. MobiDrop produces integrated machine platforms, microfluidic detection chips, extensive assays, and user-friendly software specifically designed for digital droplet PCR and single-cell multi-omic applications. Its products find applications in molecular diagnostics, cancer screening, and drug research and development, providing groundbreaking solutions that advance the quality of healthcare and research capabilities.

Polod Medtech focuses on transcatheter ultrasound therapy. The company pioneered the same interventional catheter with ultrasonic treatment and ultrasonic imaging functions at the same time and built a transcatheter ultrasonic ablation platform, transcatheter ultrasonic thrombolysis platform, and ultrasonic collaborative de calcification platform to treat multiple cardiovascular, respiratory, and digestive diseases, flexible, accurate and avoiding X-ray radiation.

Deyun Kangrui is a bio-medical high-tech enterprise that integrates R&D and the production of full-chain single-cell multi-omics technology.

Ningbo Jenscare Scientific develops solutions around structural heart disease that include the treatment of the tricuspid valve, mitral valve, aortic valve, and heart failure. The company's contact information is its physical address.

Vico Medical, established in 2018 and based in Wuhan, China, specializes in the development and production of medical devices aimed at treating cardiovascular and cerebrovascular diseases. The company offers a range of products, including atrial shunts, puncture systems, and occluders for patent foramen ovale, along with delivery systems and other related devices. Vico Medical focuses on providing innovative intervention treatment solutions for structural cardiovascular issues, contributing to the reduction of stroke and heart-related disease incidents.

HiFiBiO is a biotherapeutics company focused on harnessing the human immune system to address diseases, particularly cancer and autoimmune disorders. Founded in 2013 and based in Paris, the company specializes in proprietary single-cell technologies that facilitate drug and biomarker discovery and development. HiFiBiO's platform combines extensive biological knowledge with advanced single-cell profiling techniques, allowing for the rapid identification and advancement of antibody drugs. Through partnerships with both industry and academic institutions, HiFiBiO aims to promote open innovation and enhance patient outcomes by unlocking the therapeutic potential of the immune system.

Huamai Medtech focuses on developing advanced biomaterial platforms for the natural regeneration and reconstruction of damaged musculoskeletal tissues (bone, cartilage, tendons, etc.) in the human body. The company will launch the first batch of bone regenerative medical materials for orthopedic surgery. The main application includes small-area bone defects, repair, and reconstruction of large-area bone defects, spinal fusion surgery, and alveolar bone regeneration in dental surgery. These products will benefit hundreds of millions of patients needing bone grafts. The company is headquartered in Hangzhou, China.

Hangzhou Nano Ablation Biotech is a pioneering company focused on innovative ablation solutions utilizing bioelectric technology. It has developed a next-generation pulse ablation method known as nanosecond wave ablation, which allows for precise local ablation and addresses challenges inherent in traditional tumor treatment methods, particularly regarding tumor recurrence and metastasis. The company's technology represents a significant advancement over microsecond electric pulse technology, offering higher voltage and frequency for more effective tumor treatment. Currently, Hangzhou Nano Ablation Biotech is nearing the completion of the world's first registered clinical trial for its nanosecond wave tumor ablation technique. The company has a diverse pipeline of products aimed at treating various cancers, including liver and pancreatic cancer, as well as applications in cardiac ablation.

LungCare is a company focused on developing advanced technologies for the diagnosis of lung cancer. Its innovative products include a 3D CT scanner equipped with electromagnetic positioning and a range of bronchoscopes. These tools are designed to enhance the accuracy and reliability of lung cancer detection, supporting healthcare professionals in their efforts to diagnose patients effectively. By prioritizing precision in lung cancer diagnostics, LungCare aims to improve patient outcomes and contribute to the advancement of medical practices in oncology.

Yidianling is a technology-enabled psychology service provider based in China, offering a comprehensive platform for online counseling and therapy. The company connects users with over 15,000 psychology specialists, facilitating access to professional services that include psychological consultation, testing, and courses, as well as supervision and one-point meditation. Yidianling addresses various mental health concerns such as romantic relationships, emotional stress, family dynamics, and workplace interpersonal issues, aiming to promote healthier mental and emotional well-being among its clients.

Singlera Genomics Inc. is a biotechnology company that specializes in genetic testing and molecular diagnostic technologies. Founded in 2014 and headquartered in La Jolla, California, with additional operations in Shanghai, China, Singlera develops a methylation detection platform designed for early cancer diagnosis and prevention. The company offers a range of services, including tumor diagnosis, personalized treatment, non-invasive prenatal diagnosis, and pre-implantation genetic screening. Additionally, Singlera is focused on advancing precision medicine, aiming to provide patients with early, accurate, and informative diagnostic solutions to improve healthcare outcomes.

Medpace Medtech focuses on the treatment of functional and metabolic diseases by neuromodulation. Since its inception, Medpace Medical has developed innovative applications of neuromodulation therapy in inflammatory bowel disease, diabetes and functional gastrointestinal diseases based on cutting-edge basic research carried out at domestic and abroad.

Arigin Medical is a private company based in Shanghai, China, specializing in medical three-dimensional solutions. Founded in 2014, the company focuses on 3D printing technology specifically for orthopedic applications. Arigin Medical develops surgical guides and orthopedic splints that aim to enhance surgical procedures for knee and other lower body operations. By leveraging innovative 3D printing techniques, the company seeks to improve treatment outcomes for healthcare professionals and their patients.

Cygnus Biosciences (Beijing) Co., Ltd. is a biotechnology firm focused on the research and development of gene sequencing platforms. The company is dedicated to the industrialization of these technologies for clinical medicine screening and diagnosis. By leveraging advanced gene sequencing technology, Cygnus provides accurate and efficient biotech solutions, enabling genetic engineers and gene therapy specialists to obtain reliable data inputs and readings. This capability supports researchers in conducting experiments and deriving conclusions with enhanced effectiveness and minimal error. Through its innovative approach, Cygnus Biosciences aims to advance the field of genetics and improve clinical outcomes.

Particle Fever is a Chinese company specializing in high-end sportswear design. It operates as a "sportswear test field," focusing on innovative aesthetics and craftsmanship. The company integrates concepts from haute couture into its sportswear designs, exploring technological, cultural, and artistic dimensions to create unique products. Particle Fever aims to provide customers with scientifically designed sports apparel at reasonable prices, emphasizing both flexibility and style.

Jifu Medical is a national high-tech enterprise dedicated to the research, development, production, and sales of advanced medical products specifically for the digestive tract. With a strong emphasis on innovation, the company has established a professional research and development team and an international management platform, leading to the completion of numerous national technological innovation projects and the acquisition of over 100 national patents. Jifu Medical's flagship product line, the "Dasheng" magnetically controlled capsule endoscope system, has been under development for a decade and has received both National Medical Products Administration Class III registration and EU CE certification. These innovations have earned widespread acclaim from medical institutions, particularly for their application in non-invasive intestinal examinations, enhancing diagnostic capabilities for healthcare practitioners.

Biosis Healing specializes in regenerative medicine materials and implantable medical devices tailored for clinical surgery. The company offers a range of innovative products designed for minimally invasive procedures, including solutions for hernia repair, abdominal wall surgery, dentistry, and neurosurgery. Among its notable offerings are regenerative surgical bio-materials and implantable soft tissue repair mesh, which assist in the regeneration of tissue defects. One of its key developments is a non-crosslinked Extracellular Matrix bio-material that promotes tissue repair and functional regeneration following surgical resections. Biosis Healing is committed to advancing technology and treatment approaches through collaboration with clinical specialists, continually working to enhance its product lineup and improve surgical outcomes.

Crabyter is a data company specializing in clinical research, particularly within oncology. The company has developed a comprehensive clinical scientific research data management platform, known as Crabyter Scientific Research Bao, which includes various products such as CrabDB Scientific Research Bao Database, CrabEDC Scientific Research Bao EDC, and CrabSTAT Easy Statistics. By leveraging big data, Crabyter aims to enhance the efficiency of cancer treatment, drug development, and genetic research. Their platform is designed to offer customized data management and analysis solutions for clinical institutions and individuals, supporting advancements in oncology medicine.

Tongee Medical Technology specializes in the development and manufacturing of innovative medical devices aimed at treating metabolic diseases, including obesity, type 2 diabetes, and nonalcoholic fatty liver disease. The company focuses on creating stent medical devices, with notable products such as a gastric bypass stent system and other related stent devices. These products are designed to provide relief for patients suffering from various metabolic conditions, enhancing their quality of life through advanced medical solutions.

AccuMedical is a full-line product company in the field of neurological intervention, headquartered in Beijing with an R&D center located in California. It develops and produces medical device products for the treatment of aneurysms, preventing, and treating bleeding diseases caused by the rupture of vascular aneurysms.